Infant Formula and Toddler Drink Feeding Study
- Conditions
- Growth
- Interventions
- Other: Control Infant FormulaOther: Human MilkOther: Experimental Infant FormulaOther: Experimental Toddler DrinkOther: Human Milk Supplemental FormulaOther: Control Toddler DrinkOther: Human Milk Toddler Drink
- Registration Number
- NCT04957992
- Lead Sponsor
- Abbott Nutrition
- Brief Summary
The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months of age.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 607
- Participant is judged to be in good health as determined from participant's medical history
- Participant is a singleton from a full-term birth with a gestational age of 37 - 42 weeks by parent report
- Participant's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
- Parent(s) confirm their intention to feed their infant the study product as the sole source of feeding from Study Visit 1 to 6 months of age, and as the sole milk beverage during the first 12 months of life
- Parent(s) confirm their intention to feed the infant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage
- Parent(s) confirm their intention not to administer vitamin or mineral supplements,(except for vitamin D supplements if instructed by their healthcare professional) from enrollment through the duration of the study
- Parent(s) confirm their intention not to administer solid foods or juices to the infant from enrollment through 6 months of age unless recommended by the participant's HCP
- Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study
- If parent(s) elect to feed the participant human milk, they confirm that their infant was fed human milk since birth and confirm their intention to exclusively feed human milk as the sole source of feeding through 6 months of age.
- If parent(s) of human milk fed participant elect to supplement or wean, they confirm their intention to use the experimental supplemental/weaning formula and experimental toddler drink as the primary milk beverage.
- An adverse maternal, fetal or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development
- Awareness of a positive drug screen (including but not limited to cocaine, heroin, or methamphetamine) in the mother or participant
- Suspected maternal substance abuse including alcohol
- Participant is taking and plans to continue medications (including over the counter (OTC), such as Mylicon® for gas), home remedies (such as juice for constipation), herbal preparations, prebiotics or probiotics, or rehydration fluids that might affect GI tolerance
- Participant is in another study that has not been approved as a concomitant study by AN
- Participant has been treated with antibiotics (except for topical antibiotics, eye drops) prior to enrollment
- Participant has been treated with other medications (besides antibiotics) that in the opinion of the PI may affect growth, GI tolerance and/or development, prior to enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Feeding Group Control Infant Formula Milk based product Experimental Feeding Group Experimental Toddler Drink Milk based product with oligosaccharides Human Milk Reference Group Human Milk Human Milk Human Milk Reference Group Human Milk Supplemental Formula Human Milk Human Milk Reference Group Human Milk Toddler Drink Human Milk Control Feeding Group Control Toddler Drink Milk based product Experimental Feeding Group Experimental Infant Formula Milk based product with oligosaccharides
- Primary Outcome Measures
Name Time Method Growth Study Day 1 to 6 Months of Age weight for age z-score
- Secondary Outcome Measures
Name Time Method Incidence of respiratory infection between study groups Study Day 1 to 24 Months of Age Adverse event reports
Number of respiratory infection episodes between study groups Study Day 1 to 24 Months of Age Adverse event reports
Incidence of infection morbidity between study groups Study Day 1 to 24 Months of Age Adverse event reports
Number of episodes of infection morbidity between study groups Study Day 1 to 24 Months of Age Adverse event reports
Weight Study Day 1 to 24 Months of Age Interval weight gain per day
Length Study Day 1 to 24 Months of Age Interval length gain per day
Head Circumference Study Day 1 to 24 Months of Age Interval head circumference gain per day
Gastrointestinal Tolerance Study Day 1 to 12 months of Age Parent completed diary
Trial Locations
- Locations (43)
AIH Research
🇺🇸Pearland, Texas, United States
MedPharmics, LLC 3192
🇺🇸Phoenix, Arizona, United States
HealthStar Research
🇺🇸Glenwood, Arkansas, United States
HealthStar Research, LLC
🇺🇸Hot Springs, Arkansas, United States
The Children's Clinic of Jonesboro, P.A.
🇺🇸Jonesboro, Arkansas, United States
Applied Research Center of Arkansas
🇺🇸Little Rock, Arkansas, United States
Optumcare Colorado Springs, LLC
🇺🇸Colorado Springs, Colorado, United States
Boeson Research 3266
🇺🇸Grand Junction, Colorado, United States
TOPAZ Clinical Research, Inc.
🇺🇸Apopka, Florida, United States
Columbus Clinical Services, LLC.
🇺🇸Miami, Florida, United States
Emerald Coast OBGYN Clinical Research
🇺🇸Panama City, Florida, United States
ASCLEPES Research Centers
🇺🇸Spring Hill, Florida, United States
Jedidiah Clinical Research
🇺🇸Tampa, Florida, United States
Meridian Clinical Research 3259
🇺🇸Macon, Georgia, United States
Clinical Research Prime
🇺🇸Idaho Falls, Idaho, United States
Leavitt Clinical Research
🇺🇸Idaho Falls, Idaho, United States
Qualmedica Research
🇺🇸Evansville, Indiana, United States
Deaconess Clinic, Inc.
🇺🇸Evansville, Indiana, United States
Qualmedica Research, LLC
🇺🇸Owensboro, Kentucky, United States
Pennington Biomedical Research Center
🇺🇸Baton Rouge, Louisiana, United States
MedPharmics, LLC 3343
🇺🇸Covington, Louisiana, United States
MedPharmics Research 3369
🇺🇸Slidell, Louisiana, United States
Boeson Research 3367
🇺🇸Great Falls, Montana, United States
Boeson Research 3265
🇺🇸Kalispell, Montana, United States
Boeson Research 3267
🇺🇸Missoula, Montana, United States
Meridian Clinical Research 3264
🇺🇸Grand Island, Nebraska, United States
Meridian Clinical Research 3263
🇺🇸Hastings, Nebraska, United States
Meridian Clinical Research 3304
🇺🇸Lincoln, Nebraska, United States
Alivation Research
🇺🇸Lincoln, Nebraska, United States
University of Nebraska Medical Center 3315
🇺🇸Omaha, Nebraska, United States
University of Nebraska Medical Center 3314
🇺🇸Omaha, Nebraska, United States
Advantage Clinical Trials
🇺🇸Bronx, New York, United States
Ohio Pediatric Research Association
🇺🇸Dayton, Ohio, United States
Tribe Clinical Research LLC 3313
🇺🇸Greenville, South Carolina, United States
Tribe Clinical Research LLC 3382
🇺🇸Spartanburg, South Carolina, United States
Coastal Pediatric Research
🇺🇸Summerville, South Carolina, United States
Holston Medical Group 3301
🇺🇸Bristol, Tennessee, United States
Holston Medical Group 3046
🇺🇸Kingsport, Tennessee, United States
AVIATI Healthcare & Clinical Research
🇺🇸Memphis, Tennessee, United States
Javara Inc. 3377
🇺🇸Dallas, Texas, United States
Maximos Ob/Gyn
🇺🇸League City, Texas, United States
National Clinical Research, Inc
🇺🇸Richmond, Virginia, United States
Multicare Health System - Rockwood Pediatrics
🇺🇸Spokane, Washington, United States